CURE Pharmaceutical and Canopy Growth to produce CBD oral thin films
OXNARD, Calif. – CURE Pharmaceutical announced it is collaborating with Canopy Growth Corp. to develop a new low-dose cannabidiol (CBD) oral thin film (OTF) using CURE’s patented CUREfilm technology for global distribution. This CUREfilm license gives Canopy a dosage form that is ideal for administering cannabinoids. “This collaboration builds on our licensing agreement with Canopy
